Du surfar just nu på en begränsad version av umu.se. Vad innebär det här?

"False"
Umeå universitet
printicon
Huvudmenyn dold.

Amir Sherif

Vetenskaplig meritering: Docent

Kontakt

E-post
amir.sherif@umu.se

Verksam som

Anknytning
Universitetslektor, överläkare vid Institutionen för diagnostik och intervention Enhet: Urologi och andrologi
Plats
2, Målpunkt A42, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Does neoadjuvant chemotherapy and radical cystectomy in muscle-invasive bladder cancer obliterate survival differences between genders?
Translational Andrology and Urology, AME Publishing Company 2025, Vol. 14, (6) : 1589-1600
Sidiqi, Gina; Stauch, Hanna; Johansson, Markus; et al.
Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer
Cancer Letters, Elsevier 2025, Vol. 609
Steiner, Loïc; Eldh, Maria; Offens, Annemarijn; et al.
Imaging single particle profiler to study nanoscale bioparticles using conventional confocal microscopy
Nano Letters, American Chemical Society (ACS) 2025, Vol. 25, (6) : 2173-2180
Sych, Taras; Görgens, André; Steiner, Loïc; et al.
Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study
Frontiers in Oncology, Frontiers Media S.A. 2025, Vol. 15
Söderkvist, Karin; Häggström, Christel; Hagberg, Oskar; et al.
Long-term survival after volatile or propofol general anesthesia for bladder cancer surgery: a retrospective national registry cohort study
Anesthesiology, American Society of Anesthesiologists 2024, Vol. 140, (6) : 1126-1133
Enlund, Mats; Hållberg, Hampus; Berglund, Anders; et al.
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
BJU International, John Wiley & Sons 2024, Vol. 134, (2) : 229-238
Holmberg, Lars; Skogmar, Sten; Garmo, Hans; et al.
Don't throw out the baby with the bath water!: Editorial comment to DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer
Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 117-118
Sherif, Amir
Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry vs. data from a detailed research database
Translational Andrology and Urology, AME Publishing Company 2024, Vol. 13, (12) : 2757-2770
Wedholm, Albin; Wiberg, Erik; Styrke, Johan; et al.
Long-term patient follow-up should be routinely implemented in radiotherapy units to detect late adverse effects after cancer treatment
Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 30-31
Aas, Kirsti; Sherif, Amir
Short term outcomes after robot assisted and open cystectomy: A nation-wide population-based study
European Journal of Surgical Oncology, Elsevier 2023, Vol. 49, (4) : 868-874
Bergengren, Oskar; Belozerov, Alexej; Bill-Axelson, Anna; et al.
Novel zebrafish patient-derived tumor xenograft methodology for evaluating efficacy of immune-stimulating bcg therapy in urinary bladder cancer
Cells, MDPI 2023, Vol. 12, (3)
Kowald, Saskia; Huge, Ylva; Tandiono, Decky; et al.
Immune-activated B cells are dominant in prostate cancer
Cancers, MDPI 2023, Vol. 15, (3)
Saudi, Aws; Banday, Viqar Showkat; Zirakzadeh, A. Ali; et al.
The risk of thromboembolism in patients with muscle invasive bladder cancer before and after cystectomy depending on blood group and neoadjuvant chemotherapy: a multicentre retrospective cohort study
Journal of Personalized Medicine, MDPI 2023, Vol. 13, (9)
Schulz Hägersten, Emma; Ottosson, Kristoffer; Pelander, Sofia; et al.
A validation study of cT-categories in the Swedish national urinary bladder cancer register - Norrland University Hospital
Journal of Personalized Medicine, MDPI 2023, Vol. 13, (7)
Wiberg, Erik; Vega, Andrés; Eriksson, Victoria; et al.
Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (3) : 227-232
Abuhasanein, Suleiman; Jahnson, Staffan; Aljabery, Firas; et al.
Do not throw out the baby with the bath water
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (3) : 235-236
Abuhasanein, Suleiman; Jahnson, Staffan; Aljabery, Firas; et al.
A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer
Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 20-26
Asad, Danna; Styrke, Johan; Hagsheno, Mohammad; et al.
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study
Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56 : 14-18
Bobjer, Johannes; Hagberg, Oskar; Aljabery, Firas; et al.
Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access?: A clinical practice article
F1000 Research, F1000 Research 2022, Vol. 11
Eriksson, Victoria; Eriksson, Elisabeth; Sherif, Amir
A retrospective analysis of the de ritis ratio in muscle invasive bladder cancer, with focus on tumor response and long-term survival in patients receiving neoadjuvant chemotherapy and in chemo naïve cystectomy patients: a study of a clinical multicentre database
Journal of Personalized Medicine, MDPI 2022, Vol. 12, (11)
Eriksson, Victoria; Holmkvist, Oscar; Huge, Ylva; et al.
Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer: a Swedish retrospective multicentre study of a clinical database
Translational Andrology and Urology, AME Publishing Company 2022, Vol. 11, (8) : 1105-1115
Eriksson, Victoria; Holmlund, Jennie; Wiberg, Erik; et al.
Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer
PLOS ONE, Public Library of Science 2022, Vol. 17, (9)
Holmberg, Lars; Hagberg, Oskar; Häggström, Christel; et al.
Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
BMJ Open, BMJ Publishing Group Ltd 2022, Vol. 12, (12)
Häggström, Christel; Hagberg, Oskar; Gårdmark, Truls; et al.
Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (2) : 137-146
Liedberg, Fredrik; Kjellström, Sofia; Lind, Anna-Karin; et al.
Nomograms including UBC® Rapid Test to detect primary bladder cancer based on a multicenter data set
BJU International, John Wiley & Sons 2022, Vol. 130, (6) : 754-763
Meisl, Christina J.; Karakiewicz, Pierre I.; Einarsson, Roland; et al.
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (1) : 27-33
Russell, Beth; Liedberg, Fredrik; Hagberg, Oskar; et al.
Thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a study of renal impairment in relation to potential thromboprophylaxis
Journal of Personalized Medicine, MDPI 2022, Vol. 12, (12)
Rydell, Harriet; Ericson, Anna; Eriksson, Victoria; et al.
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
Life, MDPI 2022, Vol. 12, (8)
Rydell, Harriet; Huge, Ylva; Eriksson, Victoria; et al.
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer
Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (2) : 108-115
Bobjer, Johannes; Hagberg, Oskar; Aljabery, Firas; et al.
Proteomic profiling of tissue exosomes indicates continuous release of malignant exosomes in urinary bladder cancer patients, even with pathologically undetectable tumour
Cancers, MDPI 2021, Vol. 13, (13)
Eldh, Maria; Mints, Michael; Hiltbrunner, Stefanie; et al.
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
Bladder Cancer, IOS Press 2021, Vol. 7, (2) : 161-171
Jahnson, Staffan; Gårdmark, Truls; Hosseini, Abolfazl; et al.
Survival after radical cystectomy during holiday periods
Scandinavian journal of urology, Taylor & Francis Group 2021, Vol. 55, (4) : 276-280
Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas; et al.
Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: a nation-wide population-based study
PLOS ONE, Public Library of Science 2021, Vol. 16, (2)
Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas; et al.
Cumulative incidence of ureteroenteric strictures after radical cystectomy in a population-based Swedish cohort
Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (5) : 361-365
Magnusson, Jenny; Hagberg, Oskar; Aljabery, Firas; et al.
Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status
Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (6) : 455-460
Tenninge, S.; Mogos, H.; Eriksson, E.; et al.
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Science Translational Medicine, American Association for the Advancement of Science (AAAS) 2021, Vol. 13, (576)
Vollmer, Tino; Schlickeiser, Stephan; Amini, Leila; et al.
Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer
Investigative and Clinical Urology, The Korean Urological Association 2021, Vol. 62
Zhang, Lu; Zirakzadeh, A. Ali; Rosvall, Jesper; et al.
Abstract 6124: Translation of zebrafish tumor-derived xenograft-models for improved diagnosis and treatment planning in urinary bladder cancer patients
Cancer Research, American Association for Cancer Research 2020, Vol. 80, (6 Supplement) : 6124-6124
Ali, Zaheer; Nilsson, Anna; Vildevall, Malin; et al.
Treatment and prognosis of bladder cancer patients with other primary cancers: A nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)
BJU International, John Wiley & Sons 2020, Vol. 126, (5) : 625-632
Aljabery, Firas; Liedberg, Fredrik; Häggström, Christel; et al.
Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
World journal of urology, Springer 2020, Vol. 38 : 2207-2213
Alvaeus, Julia; Rosenblatt, Robert; Johansson, Markus; et al.
Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
Scientific Reports, Nature Publishing Group 2020, Vol. 10, (1)
Hiltbrunner, Stefanie; Mints, Michael; Eldh, Maria; et al.
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study
World journal of urology, Springer 2020, Vol. 38, (2) : 381-388
Jerlström, Tomas; Chen, Ruoqing; Liedberg, Fredrik; et al.
IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity
Scandinavian Journal of Immunology, John Wiley & Sons 2020, Vol. 92, (6)
Krantz, David; Mints, Michael; Winerdal, Malin; et al.
Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single centre retrospective prognostic study
Translational Andrology and Urology, AME Publishing Company 2020, Vol. 9, (3) : 1062-1072
Mogos, Haben; Eriksson, Elisabeth K; Styrke, Johan; et al.
The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation
International Urology and Nephrology, Springer 2020, Vol. 52, (4) : 661-669
Ottosson, Kristoffer; Pelander, Sofia; Johansson, Markus; et al.
Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival
Scandinavian journal of urology, Taylor & Francis 2020, Vol. 54, (1) : 46-51
Rosenblatt, Robert; Lorentzi, Gabriella; Bahar, Maryam; et al.
Sustainable long-term results on postoperative sexual activity after radical prostatectomy when a clinical sexologist is included in the sexual rehabilitation process: A retrospective study on 7 years postoperative outcome
Central European Journal of Urology, Warsaw: Polish Urological Association 2020, Vol. 73, (4) : 551-557
Ströberg, Peter; Ljunggren, Christina; Sherif, Amir
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer – An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
European Urology, Elsevier 2020, Vol. 77, (2) : 223-250
Witjes, J. Alfred; Babjuk, Marek; Bellmunt, Joaquim; et al.
Tumour-associated B cells in urothelial urinary bladder cancer
Scandinavian Journal of Immunology, Wiley-Blackwell 2020, Vol. 91, (2)
Zirakzadeh, A. Ali; Sherif, Amir; Rosenblatt, Robert; et al.
Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases: a nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)
Scandinavian journal of urology, Taylor & Francis 2019, Vol. 53, (5) : 332-338
Aljabery, Firas; Liedberg, Fredrik; Häggström, Christel; et al.
Visa publikationer i DiVA

Forskargrupper

Forskningsledare
Amir Sherif lab

Forskningsprojekt

1 januari 2018
Peniscancer
1 januari 2018
Testiscancer
1 januari 2018
Urinblåsecancer
Ny metod kan ge bättre träffsäkerhet vid cancer i urinblåsan

Det kan bli möjligt att i förväg se vilka patienter som svarar på cellgiftbehandling vid cancer i urinblåsan.

Läkarstudenternas ros till erfaren urolog

Amir Sherif berättar om sina drivkrafter inom forskning och undervisning samt kommande drömprojekt.